<DOC>
	<DOCNO>NCT02665637</DOCNO>
	<brief_summary>This double-blind , two-arm , parallel-group , single-dose study .</brief_summary>
	<brief_title>Study Comparing Pharmacokinetics , Safety Immunogenicity CT-P6 US-licensed Herceptin</brief_title>
	<detailed_description>This double-blind , two-arm , parallel-group , single-dose study . A total 70 healthy male subject enrol .</detailed_description>
	<mesh_term>Trastuzumab</mesh_term>
	<criteria>1 . Healthy male subject 2 . Subject voluntarily agree participate study 1 . Female . 2 . Subject medical condition disease include one . 3 . Smoker</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>